Hesperos, Inc. (HESP)

Hesperos will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Cap n/a
Revenue (ttm) 5.11M
Net Income (ttm) -773,316
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About HESP

Hesperos, Inc. is a socially-conscious company that uses our non-invasive, serum-free, multi-organ chip platform (Human-on-a-Chip) systems to provide pre-clinical analytical services with the goal of accelerating drug discovery and general toxicology testing and reducing use of animal testing. Our Human-on-a-Chip platform system mimics the process of initial patient evaluation during a clinical trial, where functional human in vitro tissues are evaluated similar to a patient undergoing medical testing to determine baseline performance metrics. ... [Read more...]

Industry Health Care
Founded 2015
CEO James F. Kronauge, Jr., Ph.D.
Employees 27
Stock Exchange NASDAQ
Ticker Symbol HESP
Full Company Profile

Financial Performance

Financial Statements

News

Hesperos IPO Registration Document (S-1)

Hesperos has filed to go public with an IPO on the NASDAQ.